U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188821188821Angiomax in Patients With HIT/HITTS Type II Undergoing CPBCompletedNo Results AvailableCardiovascular Disease|Coronary Artery Bypass SurgeryDrug: Angiomax (bivalirudin)https://ClinicalTrials.gov/show/NCT00079508
188822188822Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)CompletedNo Results AvailableMultiple SclerosisDrug: NBI-5788https://ClinicalTrials.gov/show/NCT00079495
188823188823Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)CompletedNo Results AvailableAcute Myeloid LeukemiaDrug: lestaurtinib|Drug: lestaurtinibhttps://ClinicalTrials.gov/show/NCT00079482
188824188824Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to SmokeCompletedNo Results AvailableCancer Survivor|Unspecified Adult Solid Tumor, Protocol SpecificBehavioral: smoking cessation intervention|Drug: bupropion hydrochloridehttps://ClinicalTrials.gov/show/NCT00079469
188825188825Temsirolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNo Results AvailableRefractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple MyelomaDrug: temsirolimus|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00079456
188826188826FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaTerminatedNo Results AvailableRecurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Small Lymphocytic LymphomaDrug: romidepsin|Biological: rituximab|Drug: fludarabine phosphate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00079443
188827188827Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNo Results AvailableBrenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Procedure: adjuvant therapy|Drug: paclitaxel|Drug: carboplatin|Biological: bevacizumabhttps://ClinicalTrials.gov/show/NCT00079430
188828188828Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular RetinoblastomaActive, not recruitingHas ResultsIntraocular RetinoblastomaProcedure: cryosurgery|Procedure: infrared laser therapy|Radiation: iodine I 125|Radiation: ruthenium Ru 106|Drug: carboplatin|Drug: vincristine sulfate|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00079417
18882918882917-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaCompletedNo Results AvailableAcute Undifferentiated Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Unspecified Childhood Solid Tumor, Protocol SpecificDrug: tanespimycinhttps://ClinicalTrials.gov/show/NCT00079404
188830188830Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow MalignanciesCompletedHas ResultsHematologic Malignancies|Bone Marrow Transplant RejectionDevice: allogeneic hematopoietic stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00079391
188831188831Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNo Results AvailableAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22Drug: decitabine|Drug: valproic acid|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00079378
188832188832Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the PancreasActive, not recruitingNo Results AvailablePancreatic CancerDrug: fluorouracil|Drug: gemcitabine hydrochloride|Radiation: brachytherapy|Radiation: phosphorus P32|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00079365
188833188833Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: alvocidib|Drug: gemcitabine hydrochloride|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00079352
188834188834Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem GliomaCompletedHas ResultsUntreated Childhood Brain Stem GliomaRadiation: radiation therapy|Drug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00079339
188835188835Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast CancerTerminatedHas ResultsHER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IV Breast CancerBiological: trastuzumab|Drug: ixabepilone|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00079326
188836188836Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous LeukemiaCompletedNo Results AvailableChronic Myelomonocytic Leukemia|Chronic Myelogenous LeukemiaDrug: Imatinibhttps://ClinicalTrials.gov/show/NCT00079313
188837188837Imiquimod Cream in Treating Patients With Basal Cell Skin CancerCompletedNo Results AvailableNon-melanomatous Skin CancerDrug: imiquimod|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00079300
188838188838Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: carboplatin|Drug: docetaxel|Drug: gemcitabine hydrochloride|Drug: paclitaxel|Drug: vinorelbine tartratehttps://ClinicalTrials.gov/show/NCT00079287
188839188839Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon CancerCompletedHas ResultsAdenocarcinoma of the Colon|Stage III Colon CancerDrug: irinotecan hydrochloride|Drug: oxaliplatin|Drug: leucovorin calcium|Drug: fluorouracil|Biological: cetuximab|Drug: Locally Directed Therapyhttps://ClinicalTrials.gov/show/NCT00079274
188840188840Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphoma|Small Intestine CancerDrug: CHOP regimen|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: gemcitabine hydrochloride|Drug: prednisone|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00079261
188841188841Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast CancerActive, not recruitingNo Results AvailableBreast Cancer|Hot Flashes|Menopausal Symptoms|OsteoporosisBiological: therapeutic progesterone|Drug: conjugated estrogenshttps://ClinicalTrials.gov/show/NCT00079248
188842188842CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableRecurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: temsirolimus|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00079235
188843188843Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationCompletedNo Results AvailableCancerDrug: itraconazole|Drug: voriconazolehttps://ClinicalTrials.gov/show/NCT00079222
188844188844Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond To Prior TreatmentCompletedNo Results AvailableGraft Versus Host DiseaseDrug: sirolimus|Other: questionnaire administration|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00079183
188845188845Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDietary Supplement: garlic|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00079170
188846188846Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast CancerActive, not recruitingNo Results AvailableBreast CancerBiological: incomplete Freund's adjuvant|Biological: sargramostim|Biological: telomerase: 540-548 peptide vaccinehttps://ClinicalTrials.gov/show/NCT00079157
188847188847Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: NY-ESO-1 peptide vaccine|Biological: aldesleukin|Biological: filgrastim|Biological: incomplete Freund's adjuvant|Biological: therapeutic autologous lymphocytes|Drug: cyclophosphamide|Drug: fludarabine phosphatehttps://ClinicalTrials.gov/show/NCT00079144
188848188848Oblimersen in Treating Patients With Merkel Cell CarcinomaCompletedNo Results AvailableRecurrent Neuroendocrine Carcinoma of the Skin|Stage I Neuroendocrine Carcinoma of the Skin|Stage II Neuroendocrine Carcinoma of the Skin|Stage III Neuroendocrine Carcinoma of the Skin|Stage IV Neuroendocrine Carcinoma of the SkinBiological: oblimersen sodium|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00079131
188849188849Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: docetaxel|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00079118
188850188850Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Treating Older Patients With Hodgkin's LymphomaRecruitingNo Results AvailableLymphomaBiological: bleomycin sulfate|Drug: cyclophosphamide|Drug: etoposide|Drug: mitoxantrone hydrochloride|Drug: prednisolone|Drug: procarbazine hydrochloride|Drug: vinblastine sulfatehttps://ClinicalTrials.gov/show/NCT00079105

* Görseller ve İçerik tekif hakkına sahip olabilir